Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Crescent Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −3 vs. Q4 2021
- Shares held
- 27.4M
- −2.28M (−7.7%) vs. Q4 2021
- Total value
- $31.2M
- −$11.5M (−26.9%) vs. Q4 2021
- New holders
- 3
- 9 more added
- Sold out
- 6
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 32 | $0 | 0.00% | −21,022−99.8% | Reduced |
| Carolinas Wealth Consulting LLC | 395 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 255 | $0 | 0.00% | +1+0.4% | Added |
| FinTrust Capital Advisors, LLC | 245 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $548 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,992 | $2.00K | 0.00% | −5,280−72.6% | Reduced |
| JPMorgan Chase & Co | 1,468 | $2.00K | 0.00% | +230+18.6% | Added |
| Simplex Trading, LLC | 4,119 | $4.00K | 0.00% | −95,183−95.9% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Coastal Bridge Advisors, LLC | 10,000 | $11.0K | 0.00% | +10,000 | New |
| ExodusPoint Capital Management, LP | 10,720 | $12.0K | 0.00% | −18,570−63.4% | Reduced |
| Citadel Advisors LLC | 12,519 | $14.0K | 0.00% | −83,756−87.0% | Reduced |
| Prentiss Smith & Co Inc | 14,000 | $16.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 15,804 | $18.0K | 0.00% | +4,090+34.9% | Added |
| Sigma Planning Corp | 18,000 | $21.0K | 0.00% | +18,000 | New |
| Bank of New York Mellon Corp | 26,299 | $30.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 28,004 | $32.0K | 0.00% | +1,830+7.0% | Added |
| Ieq Capital, LLC | 38,363 | $44.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 43,652 | $50.0K | 0.00% | −9,503−17.9% | Reduced |
| Susquehanna International Group, LLP | 47,640 | $54.0K | 0.00% | −217,568−82.0% | Reduced |
| Pura Vida Investments, LLC | 87,678 | $100.0K | 0.01% | +87,678 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 89,926 | $103.0K | 0.00% | −29,469−24.7% | Reduced |
| Intellectus Partners, LLC | 90,500 | $103.0K | 0.03% | +10,000+12.4% | Added |
| Susquehanna Fundamental Investments, LLC | 90,876 | $104.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 97,797 | $111.0K | 0.00% | −690−0.7% | Reduced |
| Eversept Partners, LP | 100,579 | $114.7K | 0.01% | +579+0.6% | Added |
| State Street Corp | 148,965 | $170.0K | 0.00% | +4,700+3.3% | Added |
| Bridgeway Capital Management, LLC | 155,400 | $177.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 161,300 | $184.0K | 0.00% | +993+0.6% | Added |
| Federated Hermes, Inc. | 217,116 | $248.0K | 0.00% | −128,336−37.2% | Reduced |
| D. E. Shaw & Co., Inc. | 255,684 | $291.0K | 0.00% | −12,187−4.5% | Reduced |
| Dimensional Fund Advisors LP | 271,129 | $309.0K | 0.00% | −293,259−52.0% | Reduced |
| Geode Capital Management, LLC | 363,437 | $414.0K | 0.00% | −1,669−0.5% | Reduced |
| Two Sigma Advisers, LP | 388,800 | $443.0K | 0.00% | −266,000−40.6% | Reduced |
| Millennium Management LLC | 404,189 | $461.0K | 0.00% | −287,524−41.6% | Reduced |
| Two Sigma Investments, LP | 420,819 | $480.0K | 0.00% | −189,443−31.0% | Reduced |
| Renaissance Technologies LLC | 470,600 | $536.0K | 0.00% | −130,700−21.7% | Reduced |
| BlackRock Inc. | 868,237 | $990.0K | 0.00% | −4,621−0.5% | Reduced |
| Vanguard Group Inc | 1,814,963 | $2.07M | 0.00% | −423,590−18.9% | Reduced |
| Acadian Asset Management LLC | 1,990,087 | $2.27M | 0.01% | +39,001+2.0% | Added |
| NEA Management Company, LLC | 9,089,041 | $10.4M | 0.33% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $10.9M | 0.44% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | – | – | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −146,078−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −38,533−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −34,903−100.0% | Sold out |
| XR Securities LLC | 0 | $0 | 0.00% | −10,395−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |